Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$686M |
| 2 |
Merck
MRK
|
+$536M |
| 3 |
GoDaddy
GDDY
|
+$330M |
| 4 |
CSX Corp
CSX
|
+$227M |
| 5 |
Aramark
ARMK
|
+$217M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$372M |
| 2 |
DexCom
DXCM
|
+$339M |
| 3 |
Broadcom
AVGO
|
+$321M |
| 4 |
Adobe
ADBE
|
+$280M |
| 5 |
Meta Platforms (Facebook)
META
|
+$273M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.38% |
| 2 | Healthcare | 16.14% |
| 3 | Financials | 13.58% |
| 4 | Industrials | 12.86% |
| 5 | Consumer Discretionary | 11.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Synchrony
SYF
$23.7B
| $579M | 0.31% |
18,623,457
+1,334,141
| +8% | +$42.5M |
|
77
HEICO Corp Class A
HEI.A
$35.4B
| $566M | 0.3% |
7,492,544
-83,900
| -1% | -$5.78M |
|
78
ON Semiconductor
ON
$33.8B
| $564M | 0.3% |
30,624,004
+578,266
| +2% | +$12.4M |
|
79
Cisco
CSCO
$450B
| $559M | 0.3% |
11,487,481
+195,993
| +2% | +$8.82M |
|
80
Citigroup
C
$222B
| $551M | 0.29% |
7,676,073
-2,944,553
| -28% | -$208M |
|
|
NATI
81
DELISTED
National Instruments Corp
NATI
| $550M | 0.29% |
11,386,942
-99,466
| -0.9% | -$4.53M |
|
82
Bristol-Myers Squibb
BMY
$127B
| $550M | 0.29% |
8,860,702
+1,937,785
| +28% | +$115M |
|
83
Amphenol
APH
$188B
| $529M | 0.28% |
22,511,016
-1,484,872
| -6% | -$34.5M |
|
84
Atlassian
TEAM
$22B
| $520M | 0.28% |
5,409,163
-1,662,124
| -24% | -$132M |
|
85
Teledyne Technologies
TDY
$30.4B
| $519M | 0.28% |
2,105,554
-18,610
| -0.9% | -$4.24M |
|
|
DNKN
86
DELISTED
Dunkin' Brands Group, Inc.
DNKN
| $512M | 0.27% |
6,951,640
-341,481
| -5% | -$24.7M |
|
|
XLNX
87
DELISTED
Xilinx Inc
XLNX
| $512M | 0.27% |
6,383,236
-287,292
| -4% | -$21M |
|
88
Illinois Tool Works
ITW
$81.4B
| $509M | 0.27% |
3,606,670
-167,924
| -4% | -$23.7M |
|
89
Honeywell
HON
$77.1B
| $506M | 0.27% |
3,365,660
-862,273
| -20% | -$122M |
|
90
Cimpress
CMPR
$2.37B
| $504M | 0.27% |
3,691,796
-24,172
| -0.7% | -$3.49M |
|
91
L3Harris
LHX
$55.9B
| $503M | 0.27% |
2,973,417
-77,073
| -3% | -$12.3M |
|
92
Pfizer
PFE
$140B
| $502M | 0.27% |
12,016,168
-418,489
| -3% | -$16.1M |
|
93
PayPal
PYPL
$49.5B
| $502M | 0.27% |
5,713,269
-711,758
| -11% | -$62.7M |
|
94
Costco
COST
$415B
| $498M | 0.27% |
2,120,421
+177,810
| +9% | +$40.1M |
|
95
NextEra Energy
NEE
$187B
| $497M | 0.27% |
11,854,276
-212,568
| -2% | -$9.05M |
|
96
Carlisle Companies
CSL
$13.6B
| $497M | 0.27% |
4,077,866
-208,565
| -5% | -$25.5M |
|
97
Thermo Fisher Scientific
TMO
$211B
| $496M | 0.27% |
2,034,154
-2,505
| -0.1% | -$576K |
|
|
APC
98
DELISTED
Anadarko Petroleum
APC
| $496M | 0.26% |
7,350,604
+1,363,271
| +23% | +$92M |
|
99
MSCI
MSCI
$40B
| $484M | 0.26% |
2,729,359
+73,505
| +3% | +$12.8M |
|
100
Comcast
CMCSA
$79.1B
| $480M | 0.26% |
13,553,066
-997,893
| -7% | -$35.3M |
|
Similar funds
Janus Henderson Group's Q3 2018 Portfolio in Review
As of Q3 2018, Janus Henderson Group held 1,505 positions worth $187B, up 6.7% from $175B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Janus Henderson Group's Q3 2018 filing shows 118 new, 660 increased, 620 reduced and 63 closed positions. Its largest new stake was Elanco Animal Health: 1,976,916 shares worth $69M. The largest sale was Biogen, an estimated $372M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.
- Janus Henderson Group's largest Q3 2018 buy was Elanco Animal Health: 1,976,916 shares worth $69M.
- Janus Henderson Group added most to Apple in Q3 2018, an estimated $686M increase.
- Janus Henderson Group's biggest Q3 2018 reduction was Biogen, cutting an estimated $372M.
- Janus Henderson Group fully exited Financial Engines, Inc. in Q3 2018, selling an estimated $190M.
- Janus Henderson Group's ten largest holdings make up 16% of its $187B portfolio in Q3 2018.
- Janus Henderson Group opened 118 new positions and closed 63 in Q3 2018.
- Janus Henderson Group's portfolio value rose 6.7% quarter-over-quarter to $187B.
Based on Janus Henderson Group's 13F filing for Q3 2018, filed 9 Nov 2018.